Page last updated: 2024-09-02

2-methylthio-atp and Disease Models, Animal

2-methylthio-atp has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Marrelli, SP1
Cronin, C; Gongora Nieto, M; Harrison, D; Jacobson, KA; Joshi, BV; Liang, BT; Shen, JB; Sonin, D1
Bryan, RM; Cherian, L; Golding, EM; Marrelli, SP; Robertson, CS; Steenberg, ML1

Other Studies

4 other study(ies) available for 2-methylthio-atp and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Altered endothelial Ca2+ regulation after ischemia/reperfusion produces potentiated endothelium-derived hyperpolarizing factor-mediated dilations.
    Stroke, 2002, Volume: 33, Issue:9

    Topics: Adenosine Triphosphate; Animals; Biological Factors; Brain Ischemia; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; In Vitro Techniques; Infarction, Middle Cerebral Artery; Ionophores; Male; Middle Cerebral Artery; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Reperfusion; Thionucleotides; Uridine Triphosphate; Vascular Patency; Vasodilation

2002
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:2

    Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzenesulfonates; Calsequestrin; Cardiac Output, Low; Cardiomyopathies; Disease Models, Animal; Disease Progression; Membrane Potentials; Mice; Mice, Transgenic; Myocytes, Cardiac; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Thionucleotides

2007
Endothelial-mediated dilations following severe controlled cortical impact injury in the rat middle cerebral artery.
    Journal of neurotrauma, 1998, Volume: 15, Issue:8

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Linear Models; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Penicillamine; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Thionucleotides; Vasodilation

1998